[1]Neoptolemos JP,Stocken DD,Friess H,et al.A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer[J]. N Engl J Med,2004,350:1200-1210. [2]Figiel M,Górka AK,Górecki A.Zinc ions modulate YY1 activity:relevance in carcinogenesis[J]. Cancers,2023,15.doi:10.3390/cancers15174338. [3]He X,Ge C,Xia J,et al. The zinc transporter SLC39A10 plays an essential role in embryonic hematopoiesis[J].Adv Sci,2023,10.doi:10.1002/advs.202205345. [4]Ren X,Feng C,Wang Y,et al. SLC39A10 promotes malignant phenotypes of gastric cancer cells by activating the CK2-mediated MAPK/ERK and PI3K/AKT pathways[J]. Exp Mol Med,2023,55:1757-1769. [5]Franklin RB,Zou J,Costello LC.The cytotoxic role of RREB1,ZIP3 zinc transporter,and zinc in human pancreatic adenocarcinoma[J]. Cancer Biol Ther, 2014,15:1431-1437. [6]Zhang Y,Bharadwaj U,Logsdon CD,et al. ZIP4 regulates pancreatic cancer cell growth by activating IL-6/STAT3 pathway through zinc finger transcription factor CREB[J].Clin Cancer Res,2010,16:1423-1430. [7]Cui X,Zhang Y,Yang J,et al.ZIP4 confers resistance to zinc deficiency-induced apoptosis in pancreatic cancer[J].Cell Cycle,2014,13:1180-1186. [8]Liu M,Zhang Y,Yang J,et al.ZIP4 increases expression of transcription factor ZEB1 to promote integrin α3β1 signaling and inhibit expression of the gemcitabine transpor-ter ENT1 in pancreatic cancer cells[J]. Gastroenterology,2020,158:679-692. [9]Jin H,Liu P,Wu Y,et al.Exosomal zinc transporter ZIP4 promotes cancer growth and is a novel diagnostic biomarker for pancreatic cancer[J]. Cancer Sci,2023,114:712-714. [10]Liu M,Zhang Y,Yang J,et al.Zinc-dependent regulation of ZEB1 and YAP1 coactivation promotes epithelial-mesenchymal transition plasticity and metastasis in pancreatic cancer[J].Gastroenterology,2021,160:1771-1783. [11]Nimmanon T,Ziliotto S,Ogle O,et al.The ZIP6/ZIP10 heteromer is essential for the zinc-mediated trigger of mitosis[J].Cell Mol Life Sci,2021,78:1781-1798. [12]Meng Y,Li Y,Fang D,et al.Identification of solute carrier family genes related to the prognosis and tumor-infiltrating immune cells of pancreatic ductal adenocarcinoma[J].Ann Transl Med,2022,10:57.doi:10.21037/atm-21-6341. [13]Zhu B,Huo R,Zhi Q,et al.Increased expression of zinc transporter ZIP4,ZIP11,ZnT1,and ZnT6 predicts poor prognosis in pancreatic cancer[J].J Trace Elem Med Biol,2021,65:126734.doi:10.1016/j.jtemb.2021.126734. [14]Gottesman N,Asraf H,Bogdanovic M,et al.ZnT1 is a neuronal Zn/Ca exchanger[J].Cell Calcium,2022,101:102505.doi:10.1016/j.ceca.2021.102505. [15]Falcicchia C,Tozzi F,Arancio O,et al.Involvement of p38 MAPK in synaptic function and dysfunction[J].Int J Mol Sci,2020,21:5624.doi:10.3390/ijms21165624. [16]Bakshi HA,Quinn GA,Nasef MM,et al.Crocin inhibits angiogenesis and metastasis in colon cancer via TNF-α/NF-κB/VEGF pathways[J]. Cells,2022,11:1502.doi:10.3390/cells11091502. [17]Feng G,Arima Y,Midorikawa K,et al.Knockdown of TFRC suppressed the progression of nasopharyngeal carcinoma by downregulating the PI3K/Akt/mTOR pathway[J].Cancer Cell Int,2023,23:185.doi:10.1186/s12935-023-02995-7. [18]Cousins RJ,Blanchard RK,Popp MP,et al. A global view of the selectivity of zinc deprivation and excess on genes expressed in human THP-1 mononuclear cells[J].Proc Natl Acad Sci USA,2003,100:6952-6957. [19]Amagai Y,Yamada M,Kowada T,et al.Zinc homeostasis governed by Golgi-resident ZnT family members regulates ERp44-mediated proteostasis at the ER-Golgi interface[J].Nat Commun,2023,14:2683.doi:10.1038/s41467-023-38397-6. [20]Daniels MJ,Jagielnicki M,Yeager M.Structure/function analysis of human ZnT8 (SLC30A8):a diabetes risk factor and zinc transporter[J].Curr Res Struct Biol,2020,2:144-155. [21]Zhang AMY,Xia YH,Lin JSH,et al.Hyperinsulinemia acts via acinar insulin receptors to initiate pancreatic cancer by increasing digestive enzyme production and inflammation[J].Cell Metab,2023,35:2119-2135. [22]Schubert L,Mariko ML,Clerc J,et al.MAPK pathway inhibitors in thyroid cancer:preclinical and clinical data[J].Cancers (Basel),2023,15:710.doi:10.3390/cancers15030710. [23]Singh K,Pruski M,Bland R,et al.Kras mutation rate precisely orchestrates ductal derived pancreatic intraepithelial neoplasia and pancreatic cancer[J].Lab Invest, 2021,101:177-192. [24]Lanman BA,Allen JR,Allen JG,et al.Discovery of a covalent inhibitor of KRAS(G12C) (AMG 510) for the treatment of solid tumors[J].J Med Chem,2020,63:52-65. [25]Fell JB,Fischer JP,Baer BR,et al.Identification of the clinical development candidate MRTX849,a covalent KRAS(G12C) inhibitor for the treatment of cancer[J].Med Chem,2020,63:6679-6693. |